web analytics
-1 C
Munich
Tuesday, January 25, 2022

Cannagistics Inc (OTCMKTS: CNGT) Running Northbound as Co Readies New Product Line for Market & Global3PL Gains Traction

Cannagistics Inc (OTCMKTS: CNGT) has seen a massive surge in volume and price in recent days skyrocketing out of the triple zeroes to recent highs of $0.024 per share. The stock is quickly getting noticed by investors and some big players in small caps who are accumulating at current levels. We previously reported on CNGT back on November 1, 2020 stating at the time: “Reverse Merger plays are some of the biggest runners in small caps rivaling only biotech’s in their ability to make historic shot term gains. CNGT has been heating up since the Company got new CEO Jam Rob Gietl on board who was most recently, Until March 2020 the Interim CEO of Availa Bio, Inc., a company engaged in the development of numerous patented and patent pending products in the health and wellness space. According to an 8k filed by PBIO; “Pressure BioSciences, Inc. entered into a binding letter of intent to merge with Cannaworx Holdings, Inc. Pursuant to the Second Amendment, the parties extended the September 30, 2020 deadline to October 31, 2020. 

It’s easy to see why investors are bidding CNGT Higher; pink current, the Company has a stellar management team behind it led by Jim Morrison was previously President of L’Oréal for 9 years, he acquired Redken and Matrix and led a top-line growth average above 20%.  They already have 4 products at market 2 of which were previously approved by the FDA and are currently launching a number of new products. They also own a valuable intellectual property portfolio with numerous patents and patents pending. CNGT has an excellent stock structure with 266,242,608 shares outstanding of which 94,097,582 are restricted leaving 172,327,026 free trading shares. CNGT trades at a total market capitalization of $3,274,784.  CNGT popped over $0.10 per share this time last year and investors are looking for a return to these levels and a break over. CNGT has liquidity, momentum and a growing shareholder base bidding the stock higher. 

Cannagistics, Inc. (OTC: CNGT) is a U.S. corporation that operates both general and specialty 3PLs (3rd party logistics) with a focus on supply chain management, reverse logistics, warehousing, and transportation, and currently developing industry-specific technology platforms. The Company owns a valuable intellectual property portfolio with numerous patents and patents pending. 

Global3PL (Ontario, Canada) is the Company’s general commodities operation, with warehouses in Canada and the U.S. that provide monthly and just-in-time inventory, pick and ship, custom house brokerage, as well as international freight forwarding, expedited and deferred air, local, regional, and North American consumer household pickup and delivery, less-than-truckload (“LTL”), truckload (TL). 

Cannagistics, Inc. (CNGT Canadian subsidiary) is a cannabis-specific logistics company aimed at streamlining the fragmented cannabis marketplace. The first Canadian company to obtain its own bonded warehouse license for cannabis, we’re also developing the most robust supply chain technology platform specifically for the cannabis ecosystem — to tap the enormous opportunities in the emerging global cannabis marketplace With an intent to solve pain points, we’ll use technology to streamline the complexities of coordinating compliance (state by state and country by country), logistics, international clearances, information, and product shelf-life tracking, powered by services by our knowledge-based operations team 

The Company has a stellar management team behind it; CEO Jim Morrison was previously President of L’Oréal for 9 years, he acquired Redken and Matrix and led a top-line growth average above 20%. As CEO, he headed the first celebrity-driven video shopping app in partnership with SPRINT; Graham Webb, one of the most successful startups in hair care; and Sexy Hair Concepts for four years. 

To Find out the inside Scoop on CNGT Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

CNGT

Dr. Babak “Bobby” Ghalili, DMD, is one of the foremost periodontal and reconstructive dental surgeons in the field, he is an Associate Professor of Periodontal Surgery at New York University and the University of Medicine and Dentistry of New Jersey. Dr. Ghalili is a graduate of Brandeis University, Tufts University, and UMDMJ, and author of 21 patents (6 awarded patents and 15 patent pending). 

On January 3 CNGT reported it is poised to start its marketing and promotion of its new product line in the 1st Quarter of 2022. 

The Company’s current products include: (there is an excellent listing of the Company’s products and patents in their most recent 10k)

ImmuniZinTM (Immune Booster) containing a FDA cleared formulation and ingredient for immune boosting and T-cell enhancement 

Canagel® – (Anhydrous Hydrogel Composition and delivery system). Revolutionary, patented, oral transmucosal delivery of CBD/Phycannabionoids in the form of an oral strip that melts in the mouth. 

Veterinary Cannabinoid and Menthol Compositions and Methods 

KidzStrips® – Thin Film Toothpaste Strip, United States Patent and European Patent 

HydroSoil® -Water retaining Hemp enhanced fertilizer, water plant once every two weeks 

IcyEase – Adhesive Ice Pack for muscle/joint pain to cool surface and address pain. 

Slim-D – Appetite-suppressant oral strip with 50 mg Hoodia & 10 mg Full Spectrum Phytocannabinoid 

Energy Lighting Strips – High caffeine fast dissolving oral energy strip with Matcha Green Tea and Hemp/Full Spectrum Phytocannabinoid 

Silverpro – Revolutionary technology combining genuine silver yarn with low-static carbon fibers, to create the world’s most advanced-compression pain relief fabric. 

Jim Morrison, President/CEO, stated, “I am extremely excited to bring these groundbreaking products to the market. My experience and background, along with the years of contacts, allow me to capitalize on the relationships developed over the years to assist the Company.” 

For more on CNGT subscribe Right Now!

CNGT has seen a massive surge in volume and price in recent days skyrocketing out of the triple zeroes to recent highs of $0.024 per share. The stock is quickly getting noticed by investors and some big players in small caps who are accumulating at current levels. We previously reported on CNGT back on November 1, 2020 stating at the time: “Reverse Merger plays are some of the biggest runners in small caps rivaling only biotech’s in their ability to make historic shot term gains. CNGT has been heating up since the Company got new CEO Jam Rob Gietl on board who was most recently, Until March 2020 the Interim CEO of Availa Bio, Inc., a company engaged in the development of numerous patented and patent pending products in the health and wellness space. According to an 8k filed by PBIO; “Pressure BioSciences, Inc. entered into a binding letter of intent to merge with Cannaworx Holdings, Inc. Pursuant to the Second Amendment, the parties extended the September 30, 2020 deadline to October 31, 2020.  It’s easy to see why investors are bidding CNGT Higher; “pink current” the Company has a stellar management team behind it led by Jim Morrison was previously President of L’Oréal for 9 years, he acquired Redken and Matrix and led a top-line growth average above 20%.  They already have 4 products at market 2 of which were previously approved by the FDA and are currently launching a number of new products. They also own a valuable intellectual property portfolio with numerous patents and patents pending. CNGT has an excellent stock structure with 266,242,608 shares outstanding of which 94,097,582 are restricted leaving 172,327,026 free trading shares. CNGT trades at a total market capitalization of $3,274,784.  CNGT popped over $0.10 per share this time last year and investors are looking for a return to these levels and a break over. CNGT has liquidity, momentum and a growing shareholder base bidding the stock higher. We will be updating on CNGT when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CNGT.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in CNGT either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.